Literature DB >> 27059485

Effects of Danhong Injection (丹红注射液) and its main components on anticoagulation and fibrinolysis in cultured vein endothelial cells.

Yu-yan Zhang1, Hui-fen Zhou1, Jie-hong Yang1, Yu He2, Xiao-qiang Chen3, Katsuyoshi Nishinari3, Hao-fang Wan2, Hai-tong Wan4.   

Abstract

OBJECTIVE: To observe the effects of Danhong Injection (丹红注射液) and its main components, including daiclzein and hydroxysafflor yellow A (HSYA), on the anticoagulation, fibrinolysis, anti-apoptosis in hypoxia model of vein endothelial cells (VECs).
METHODS: VECs were prepared and were put in a hypoxia environment, which consisted of mixed gas of 95% N and 5% CO mixed gas, when reached confluent culture. Five groups used different treatments, including normal control group, hypoxia group, daiclzein group, HSYA group and Danhong Injection group. The VECs were identified by fluorescence double labeling methods. The morphology was observed by a phase contrast microscopy. The effects of Danhong Injection, daiclzein and HSYA on 6 keto prostaglandin F1α (6-keto-PGF1α) level was measured by the method of radioimmunoassay (RIA). Superoxide dismutase (SOD) activity was tested by water soluble tetrazolium salt. The content of malondialdehyde (MDA) was measured by thiobarbituric acid. The activities of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI) were measured by the method of chromogenic substrate. The contents of endothelin (ET) and nitric oxide (NO) were detected by non-equilibrium RIA and enzymelinked immunosorbent assay. Cells apoptosis rate was determined by flow cytometry.
RESULTS: Compared with the normal control group, the floating cells number, PAI activity, ET and MDA contents, and cells apoptosis rate in the culture solution of hypoxia group were all significantly increased, whereas the 6-keto-PGF1α and NO contents, and t-PA and SOD activities were decreased significantly (P<0.01). Compared with the hypoxia group, Danhong Injection markedly increased the 6-keto-PGF1α content and SOD activity, regulated PAI and t-PA activities, ET and NO contents, and decreased MDA content and cells apoptosis rate (P<0.05 or P<0.01).
CONCLUSIONS: Danhong Injection and its main components played an important role in protecting primary VECs from hypoxic damage by regulating the secretion and vasomotor function of VECs. The function of Danhong Injection was most remarkable.

Entities:  

Keywords:  Chinese medicine; Danhong Injection; anticoagulation; daiclzein; fibrinolysis; hydroxysafflor yellow A; vein endothelial cells

Mesh:

Substances:

Year:  2016        PMID: 27059485     DOI: 10.1007/s11655-016-2498-x

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  31 in total

1.  Endothelial cell culture: beginnings of modern vascular biology.

Authors:  Ralph L Nachman; Eric A Jaffe
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 2.  Secretory dynamics of tPA and its modulation by PAI-1 in vascular system.

Authors:  Yuko Suzuki; Tetsumei Urano
Journal:  Rinsho Ketsueki       Date:  2009-05

3.  [Protective effect of carnosine on the injury of rat vascular endothelial cells induced by hypoxia].

Authors:  Jian Bai; Ge Chi; Jun Zhang; Li-na Liu; Miao Fan; Hai-dong Liu; Wei-wei Li; Jing Yang
Journal:  Zhongguo Ying Yong Sheng Li Xue Za Zhi       Date:  2010-02

4.  Advances in stroke therapy.

Authors:  Hayder Jaffer; Viola B Morris; Desiree Stewart; Vinod Labhasetwar
Journal:  Drug Deliv Transl Res       Date:  2011-12-01       Impact factor: 4.617

Review 5.  Brain protection: physiological and pharmacological considerations. Part I: The physiology of brain injury.

Authors:  J Murdoch; R Hall
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

Review 6.  [Vascular endothelial cell development and underlying mechanisms].

Authors:  Xu Wang; Jing-Wei Xiong
Journal:  Yi Chuan       Date:  2012-09

7.  Protective effect of Danhong injection on cerebral ischemia-reperfusion injury in rats.

Authors:  Yu He; Haitong Wan; Yueguang Du; Xiaodong Bie; Tao Zhao; Wei Fu; Panke Xing
Journal:  J Ethnopharmacol       Date:  2012-09-23       Impact factor: 4.360

8.  Inhibitory effect of cryptotanshinone on angiogenesis and Wnt/β-catenin signaling pathway in human umbilical vein endothelial cells.

Authors:  Qian Chen; Qin Zhuang; Wei Mao; Xiao-ming Xu; Li-hui Wang; Hai-bing Wang
Journal:  Chin J Integr Med       Date:  2014-04-16       Impact factor: 1.978

9.  Reactive oxygen species-dependent endothelin signaling is required for augmented hypoxic sensory response of the neonatal carotid body by intermittent hypoxia.

Authors:  Anita Pawar; Jayasri Nanduri; Guoxiang Yuan; Shakil A Khan; Ning Wang; Ganesh K Kumar; Nanduri R Prabhakar
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-24       Impact factor: 3.619

10.  Nitric oxide and hypoxia stimulate erythropoietin receptor via MAPK kinase in endothelial cells.

Authors:  Bojana B Beleslin Cokic; Vladan P Cokic; Sukanya Suresh; Stacey Wirt; Constance Tom Noguchi
Journal:  Microvasc Res       Date:  2014-02-08       Impact factor: 3.514

View more
  3 in total

1.  Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection.

Authors:  Ming Lyu; Chun-Lin Yan; Hai-Xin Liu; Tai-Yi Wang; Xin-Hui Shi; Jin-Ping Liu; John Orgah; Guan-Wei Fan; Ji-Hong Han; Xiao-Ying Wang; Yan Zhu
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

2.  Efficacy of Danhong Injection on Serum Concentration of TNF-α, IL-6 and NF-κB in Rats with Intracerebral Hemorrhage.

Authors:  Chen Peng; Shibo Duan; Lou Gang
Journal:  Open Life Sci       Date:  2018-04-10       Impact factor: 0.938

3.  Danhong Injection Protects Hemorrhagic Brain by Increasing Peroxiredoxin 1 in Aged Rats.

Authors:  Shang Wang; Lie Yu; Guifang Sun; Yu Liu; Wentao Hu; Yanru Liu; Tao Peng; Xiaojun Wang; Jingliang Cheng; Aravintakumar Sr; Bo Qin; Hong Lu
Journal:  Front Pharmacol       Date:  2020-03-25       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.